Genentech wins FDA approval of drug to treat two blinding eye diseases For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | January 31, 2022 The drug, which will cost $2,190 per dose when sales begin in the coming weeks, ultimately can be dosed every one to four months. Posted in Sacramento Business Journal